MapEnhance Gives You More

Specialty Datasets Add Context to the Patient Journey

MapEnhance extends the value of our industry-leading Healthcare Map and provides the deepest and most complete view into the patient journey. 

Now, you can select and access exclusive, highly-curated data sources — including lab, genomics, oncology Electronic Medical Record (EMR) data, race and ethnicity, social determinants of health (SDoH), mortality, and more — all carefully curated and refined by Komodo data scientists.

TALK TO AN EXPERT
layers03

Obtain Real-World Data and Analytics

MapEnhance offers a fully integrated full-stack approach to obtaining real-world data and analytics. You can layer multiple datasets onto our comprehensive claims-based foundation via a single contract, and we deliver a pre-integrated, fit-for-purpose data productso you can get the insights you need faster.

A BETTER WAY

The MapEnhance Advantage

Comprehensive insights start with Komodo’s industry-leading Healthcare Map, providing an average 7+ years of the patient journey for more than 330 million unique individuals in the U.S.

TIMELY

Daily updates that provide the most up-to-date view of the market

hexagon-blue
hexagon-blue
COMPREHENSIVE

Deep insight into the patient journey provider-complete and payer-complete Mx claims, retail, specialty, PBM Rx claims

hexagon-blue
LINKABLE

Connect the Healthcare Map to other sources using commonly used de-identified tokens 

MapEnhance Gives You More

MapEnhance builds on our unmatched foundation to bring new depth to patient journeys and help answer questions previously out of reach.

layers01a

KOMODO-BUILT DATA ENHANCEMENTS

Our high-fidelity specialty data products are rigorously de-duplicated, cleaned, formatted, and standardized by Komodo data scientists. Choose from datasets such as lab, clinical encounters, race and ethnicity, mortality data, and more.

KOMODO PARTNER DATA ENHANCEMENTS

Komodo also offers specialized and proprietary assets to enhance any patient cohort within the Healthcare Map.

layers0001 1
MapEnhance in Action
COMMERCIAL
CLINICAL DEVELOPMENT
HEOR
PRECISE PATIENT IDENTIFICATION

Refine patient segmentation for targeted oncology treatment by integrating biomarker, demographic, and claims data.

Commercial 2-1
ACCURATE PATIENT DIAGNOSIS

Integrate lab results and claims data to identify key blood panel indicators, ensuring an accurate patient diagnosis.

Commercial 3-1
TRACK BRAND PERFORMANCE

Refine the patient cohort definition to assess brand utilization within the eligible lung cancer patient population over time.

ClinDev 1-1
IDENTIFY TRIAL RECRUITMENT OPPORTUNITIES

Layer clinical and demographic data onto the non-Hodgkin's lymphoma population to characterize patients who aren't responding to first- and second-line therapies and might benefit from a new therapy clinical trial.

ClinDev 2-1
DESIGN MORE INCLUSIVE TRIALS

Enhance understanding of patient journeys across different races and ethnicities to inform clinical trial strategy and inclusion/exclusion criteria.

ClinDev 3-1
INFORM CLINICAL ENDPOINTS

Enhance understanding of therapy effectiveness among specific disease populations to select more precise clinical endpoints.

HEOR 1-1
BUILD PREDICTIVE MODELS

Leverage detailed lab results and patient characteristics data to build a predictive model that will identify patients with a rare disease.

HEOR 2-1
EVALUATE ENDPOINTS AND OUTCOMES

Perform a real-world evaluation of progression-free survival after initiation of an oncology drug.

HEOR 3-1
DRIVE PRECISION MEDICINE

Use specific biomarker data for precise patient identification and segmentation to support targeted treatment and assess the real-world differences in treatment rates and patterns.